These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11923638)

  • 1. Safety and pharmacokinetics of p792, a new blood-pool agent: results of clinical testing in nonpatient volunteers.
    Gaillard S; Kubiak C; Stolz C; Bonnemain B; Chassard D
    Invest Radiol; 2002 Apr; 37(4):161-6. PubMed ID: 11923638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and pharmacokinetics of a new liposomal liver-specific contrast agent for CT: results of clinical testing in nonpatient volunteers.
    Spinazzi A; Ceriati S; Pianezzola P; Lorusso V; Luzzani F; Fouillet X; Alvino S; Rummeny EJ
    Invest Radiol; 2000 Jan; 35(1):1-7. PubMed ID: 10639031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results.
    Port M; Corot C; Rousseaux O; Raynal I; Devoldere L; Idée JM; Dencausse A; Le Greneur S; Simonot C; Meyer D
    MAGMA; 2001 May; 12(2-3):121-7. PubMed ID: 11390267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical and biological evaluation of P792, a rapid-clearance blood-pool agent for magnetic resonance imaging.
    Port M; Corot C; Raynal I; Idee JM; Dencausse A; Lancelot E; Meyer D; Bonnemain B; Lautrou J
    Invest Radiol; 2001 Aug; 36(8):445-54. PubMed ID: 11500594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol.
    Corot C; Violas X; Robert P; Gagneur G; Port M
    Invest Radiol; 2003 Jun; 38(6):311-9. PubMed ID: 12908698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity.
    Port M; Corot C; Violas X; Robert P; Raynal I; Gagneur G
    Invest Radiol; 2005 Sep; 40(9):565-73. PubMed ID: 16118549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal functional contrast-enhanced magnetic resonance imaging: evaluation of a new rapid-clearance blood pool agent (p792) in sprague-dawley rats.
    Mandry D; Pedersen M; Odille F; Robert P; Corot C; Felblinger J; Grenier N; Claudon M
    Invest Radiol; 2005 May; 40(5):295-305. PubMed ID: 15829826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic behavior of gadoteridol injection.
    McLachlan SJ; Eaton S; De Simone DN
    Invest Radiol; 1992 Aug; 27 Suppl 1():S12-5. PubMed ID: 1506147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits.
    Ruehm SG; Christina H; Violas X; Corot C; Debatin JF
    Magn Reson Med; 2002 Nov; 48(5):844-51. PubMed ID: 12417999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved evaluation of myocardial perfusion and viability with the magnetic resonance blood pool contrast agent p792 in a nonreperfused porcine infarction model.
    Peukert D; Kaufels N; Laule M; Schnorr J; Carme S; Farr T; Schönenberger E; Taupitz M; Hamm B; Dewey M
    Invest Radiol; 2007 Apr; 42(4):248-55. PubMed ID: 17351432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers.
    Staks T; Schuhmann-Giampieri G; Frenzel T; Weinmann HJ; Lange L; Platzek J
    Invest Radiol; 1994 Jul; 29(7):709-15. PubMed ID: 7960618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR angiography with a new rapid clearance blood pool agent (P792): initial experience in rabbits.
    Ruehm SG; Schmitz-Cristina H; Violas X; Corot C; Debatin JF
    Acad Radiol; 2002 Aug; 9 Suppl 2():S407-8. PubMed ID: 12188291
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of gadoteridol injection: U.S. clinical trial experience.
    Olukotun AY; Parker JR; Meeks MJ; Lucas MA; Fowler DR; Lucas TR
    J Magn Reson Imaging; 1995; 5(1):17-25. PubMed ID: 7696805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function.
    Swan SK; Baker JF; Free R; Tucker RM; Barron B; Barr R; Seltzer S; Gazelle GS; Maravilla KR; Barr W; Stevens GR; Lambrecht LJ; Pierro JA
    J Magn Reson Imaging; 1999 Feb; 9(2):317-21. PubMed ID: 10077031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model.
    Bourasset F; Dencausse A; Bourrinet P; Ducret M; Corot C
    MAGMA; 2001 May; 12(2-3):82-7. PubMed ID: 11390260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs.
    Dirksen MS; Lamb HJ; Kunz P; Robert P; Corot C; de Roos A
    Radiology; 2003 Jun; 227(3):802-8. PubMed ID: 12676975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment.
    Swan SK; Lambrecht LJ; Townsend R; Davies BE; McCloud S; Parker JR; Bensel K; LaFrance ND
    Invest Radiol; 1999 Jul; 34(7):443-8. PubMed ID: 10399633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
    Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
    Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative dynamic contrast enhanced MRI of experimental synovitis in the rabbit knee: comparison of macromolecular blood pool agents vs. Gadolinium-DOTA.
    Watrin-Pinzano A; Loeuille D; Goebel JC; Lapicque F; Walter F; Robert P; Netter P; Corot C; Gillet P; Blum A
    Biomed Mater Eng; 2008; 18(4-5):261-72. PubMed ID: 19065032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent.
    VanWagoner M; O'Toole M; Worah D; Leese PT; Quay SC
    Invest Radiol; 1991 Nov; 26(11):980-6. PubMed ID: 1743922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.